Trial Details
COMPLETEDBasic Information
| Clinical ID | c4599 |
|---|---|
| Identifier | NCT00269854 |
| Trial Title | An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Infliximab 5 mg/kg|DRUG: Infliximab 10 mg/kg|DRUG: Infliximab 20 mg/kg|DRUG: Placebo |
Participant Information
| Sponsor | Centocor, Inc. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 1995-06 |
|---|---|
| Primary Completion Date | 1996-10 |
| Completion Date | 1996-10 |